Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
CC transcript
|
|
MEDICIS PHARMACEUTICAL CORP (MRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/16/2012 |
8-K/A
| Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits|
Docs:
|
"Consent of KPMG LLP",
"Audited consolidated financial statements of Graceway Pharma Holding Corp. and Subsidiaries as of December 31, 2010 and 2009 and for the years ended December 31, 2010, 2009 and 2008 and the notes related thereto",
"Unaudited condensed consolidated financial statements of Graceway Pharma Holding Corp. and Subsidiaries as of September 30, 2011 and December 31, 2010 and for the interim periods ended September 30, 2011 and 2010 and the notes related thereto",
"Unaudited pro forma condensed combined financial information of the Company and Graceway Pharma Holding Corp. and Subsidiaries for the year ended December 31, 2010 and as of and for the nine months ended September 30, 2011 and the notes related thereto" |
|
| 09/08/2011 |
8-K/A
| Submission of Matters to a Vote of Security Holders |
| 10/21/2008 |
8-K/A
| Form 8-K/A -- Current report [amend] |
| 09/08/2008 |
8-K/A
| Financial Statements and Exhibits|
Docs:
|
"Consent of Independent Auditors",
"Audited financial statements of LipoSonix, Inc. for the years ended December 31, 2007 and 2006 and for the period from December 13, 2000 (inception) through December 31, 2007",
"Unaudited condensed financial statements of LipoSonix, Inc. as of June 30, 2008 and for the six month periods ended June 30, 2008 and 2007",
"Unaudited pro forma condensed combined balance sheet as of June 30, 2008 and unaudited pro forma condensed combined statements of operations for the six months ended June 30, 2008 and the year ended December 31, 2007" |
|
| 01/29/2002 |
8-K/A
| Financial statements and exhibits |
| 01/09/1998 |
8-K/A
| Financial statements and exhibits |
|
|